0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¦ 2Çü ´ç´¢º´È¯ÀÚ ¼ºº° ´ë»çÁõÈıº À¯º´·ü°ú À§Çè¿äÀÎ Â÷ÀÌ

Differences in Prevalence and Risk Factors of the Metabolic Syndrome by Gender in Type 2 Diabetic Patients

¼ºÀΰ£È£ÇÐȸÁö 2006³â 18±Ç 1È£ p.3 ~ 9
KMID : 0367020060180010003
±èÈñ½Â ( Kim Hee-Seung ) - °¡Å縯´ëÇб³ °£È£´ëÇÐ

Á¤¼±ÇÏ ( Chong Seon-Ha ) - °¡Å縯´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose: The purpose of this study was to assess the difference between prevalence and risk factors of the metabolic syndrome(MS) by gender in type2 diabetic patients.

Method: 108 participants(males 69, females 39) were recruited from the endocrinology outpatient department of a tertiary care hospital in an urban city. MS was defined by a third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation , and treatment of high blood cholesterol in adults(Adult Treatment Panel ¥²)(ATP ¥²), and abdominal obesity was determined by Asia- Pacific criteria in waist circumference.

Results: The prevalence of MS by definition of NCEP- ATP¥² and the Asia-Pacific criteria in waist circumference was 39.3% in males and 66.7% in females type2 diabetic patients. The abdominal obesity prevalence was seen in 44.9% of males and in 79.5% of females patients. The prevalence of low HDL-cholesterolemia in serum was 26.2% in male, 52.8% in female type2 diabetic patients.

Conclusion: These results show that nurses should focus on female diabetic patients for preventing MS.
KeyWords
2´ç´¢º´, ´ë»çÁõÈıº, À¯º´·ü, À§Çè¿äÀÎ
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed